Scripps MD Anderson Cancer Center

https://www.Scripps.org/HemOncCME

 

Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020
Avatar

Treatment of R/R CLL: Efficacy and Safety of Ibrutinib, PFS Benefit With VenR, LOXO-305 Is Highly Effective in Heavily Pretreated B-cell Malignancies & CAR T-cell Therapy is a Promising Alternative

By Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020 FEATURING Nitin Jain
By Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020 FEATURING Nitin Jain
26 views
March 4, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
Malignant Hematology
18:24
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

State-Of-The-Art in AML Therapy: High-dose ARA-C Induction Improves …

Feat. H. Kantarjian
17:15
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

State-Of-The-Art in AML Therapy: FLT3, IDH1-2, CD33 & CD123, Ven…

Feat. H. Kantarjian
22:53
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

2019 ASH Update on the First-Line Therapy in Follicular Lymphoma: Ri…

Feat. A. Zelenetz
22:19
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

PI3K Inhibitors Are Highly Active in R/R Follicular Lymphoma, New Do…

Feat. A. Zelenetz
13:22
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Treatment Options for Young "Fit" (FCR Eligible) CLL Pts: …

Feat. N. Jain
15:04
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Treatment Options for Older CLL Pts: BTKi Lead to Impressive PFS, Ti…

Feat. N. Jain
11:59
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Treatment of R/R CLL: Efficacy and Safety of Ibrutinib, PFS Benefit …

Feat. N. Jain
18:14
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Management of ET and PV in 2020: Ruxolitinib in Pts with HU-Resistan…

Feat. R. Mesa
19:31
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Management of MF in 2020: Rux Failure, Fedratinib Approval, Data on …

Feat. R. Mesa
12:17
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

CD19 Directed CAR-T Cell Therapy Schema & Toxicities (CRS & …

Feat. D. Maloney
23:22
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

CAR T-cells in DLBCL - Review of Tisa-cel, Axi-cel and Liso-cel Data…

Feat. D. Maloney
07:52
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

KTE-X19: A CAR T-Cell Option for Mantle Cell Lymphoma & Challeng…

Feat. D. Maloney
12:32
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

DLBCL - Strategies to Improve Beyond R-CHOP-21: Intensification, Bet…

Feat. C. Flowers
16:06
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Rituximab, Lenalidomide, and Ibrutinib Prior to Chemo in Newly Diagn…

Feat. C. Flowers
09:38
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

R/R DLBCL: Auto-transplant in the Pre-Rituximab Era, Polatuzumab Ved…

Feat. C. Flowers
20:08
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Does Rituximab Treated Patient Need Immunization? Case of 41 y/o Man…

Feat. L. Malpica Castillo
06:35
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Immunizations to Prevent Infections in 25 y/o Woman with Refractory …

Feat. L. Malpica Castillo
05:05
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Immunization and Infection Prevention Strategy for 18 y/o Woman With…

Feat. L. Malpica Castillo
07:48
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Treatment of 75 y/o Man With Acquired Factor VIII Deficiency - Recom…

Feat. L. Malpica Castillo
04:49
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Immunization Strategy for 41 y/o Woman With Refractory Antiphospholi…

Feat. L. Malpica Castillo
10:26
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

T-cell Lymphoma: Classification of PTCL, Prognosis by Clinical Featu…

Feat. A. Shustov
16:46
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Treatment Options for R/R PTCL: Non-Curative & Curative Intent T…

Feat. A. Shustov
17:17
Scripps Cancer Center's 40th Annual Conference: Clinical Hematology & Oncology 2020

Emergence of New Frontline PTCL Therapies: Data on Brentuximab Vedot…

Feat. A. Shustov